Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: NMR Biomed. 2015 Oct 27;28(12):1716–1725. doi: 10.1002/nbm.3437

Table 2.

Characteristics of the chronic liver disease patient groups with and without clinically significant fibrosis.

Variable No or mild fibrosis (n=10) Significant fibrosis (n=6)
Fibrosis score (number of patients)
 F0 6 0
 F1 4 0
 F2 0 2
 F3 0 2
 F4a 0 2
Inflammation score (number of patients)
 A0 1 0
 A1 5 0
 A2 4 3
 A3 0 1
Steatosis score (number of patients)
 0 8 2
 1 1 2
 2 1 0
Mean age (SD) (years) 55.1 (7.2) 61.7 (4.1)
Mean BMI (SD) (kg/m2) 28.1 (3.2) 27.5 (2.2)
Mean AST (SD) (IU/L) 45.9 (22.6) 121.2 (175.9)
Mean ALT (SD) (IU/L) 73.5 (48.1) 125.2 (156.8)
Mean platelet count (SD) (109/L) 197 (55) 168 (47)
Mean total bilirubin (SD) (mg/dL) 0.8 (1.3) 0.7 (0.5)
Mean albumin (SD) (g/dL) 4.55 (0.25) 4.20 (0.40)
Mean AST/ALT ratio (SD) 0.69 (0.21) 0.87 (0.15)
Mean APRI (SD) 0.66 (0.41) 2.26 (3.52)
Mean MPF histogram mode (SD) (%)b 5.94 (0.26) 6.49 (0.36)
a

Score is assigned to cirrhosis patients without biopsy based on the clinical diagnosis.

b

Values are significantly different according to Mann-Whitney U test (P=0.002)